ABBV-3373

ABBV-3373 is an anti-TNF GRM steroid ADC being investigated to treat rheumatoid arthritis.

Type of Molecule

Biologic

Target

TNF

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Rheumatoid Arthritis (RA) n/a
Phase 2